Literature DB >> 10585765

Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains.

L E Matesic1, A De Maio, R H Reeves.   

Abstract

Lipopolysaccharide (LPS) induces proliferation of splenic B-cells, and this response was found to be significantly lower in A/J than in C57BL/6J (B6) mice. Several strains and substrains mirrored the high and low responses of B6 and A/J. Assessment of 26 AXB/BXA recombinant inbred (RI) mouse strains identified 23 strains with a low (A/J-like), high (B6-like), or intermediate response. The three remaining RI strains exhibited a novel hyperresponsive phenotype significantly different from that of either founder strain. RI analysis identified four suggestive loci contributing to the LPS response, two of which were confirmed by analysis of congenic strains containing the donor genomic segment from a high- or low-responder strain on the opposite background. The combination of A/J and B6 alleles fixed to homozygosity at the four suggestive loci would occur in only 1 of 256 intercross progeny, but occurred several times among the RI strains. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585765     DOI: 10.1006/geno.1999.5986

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  A locus on chromosome 9 is associated with differential response of 129S1/SvImJ and FVB/NJ strains of mice to systemic LPS.

Authors:  Ivana V Yang; Holly R Rutledge; Jun Yang; Laura A Warg; Sergio D Sevilla; David A Schwartz
Journal:  Mamm Genome       Date:  2011-07-01       Impact factor: 2.957

2.  Parental genetic contributions in the AXB and BXA recombinant inbred mouse strains.

Authors:  Daniel R Prows; Michelle L Horner
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

3.  Genetic regulation of Zfp30, CXCL1, and neutrophilic inflammation in murine lung.

Authors:  Holly Rutledge; David L Aylor; Danielle E Carpenter; Bailey C Peck; Peter Chines; Lawrence E Ostrowski; Elissa J Chesler; Gary A Churchill; Fernando Pardo-Manuel de Villena; Samir N P Kelada
Journal:  Genetics       Date:  2014-08-11       Impact factor: 4.562

4.  Identification of novel genes that mediate innate immunity using inbred mice.

Authors:  Ivana V Yang; Claire M Wade; Hyun Min Kang; Scott Alper; Holly Rutledge; Brad Lackford; Eleazar Eskin; Mark J Daly; David A Schwartz
Journal:  Genetics       Date:  2009-10-05       Impact factor: 4.562

5.  Reciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time.

Authors:  Daniel R Prows; Abby V Winterberg; William J Gibbons; Benjamin B Burzynski; Chunyan Liu; Todd G Nick
Journal:  Physiol Genomics       Date:  2009-05-05       Impact factor: 3.107

6.  Integrating murine gene expression studies to understand obstructive lung disease due to chronic inhaled endotoxin.

Authors:  Peggy S Lai; Oliver Hofmann; Rebecca M Baron; Manuela Cernadas; Quanxin Ryan Meng; Herbert S Bresler; David M Brass; Ivana V Yang; David A Schwartz; David C Christiani; Winston Hide
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

7.  Baseline and innate immune response characterization of a Zfp30 knockout mouse strain.

Authors:  Lucas T Laudermilk; Adelaide Tovar; Alison K Homstad; Joseph M Thomas; Kathryn M McFadden; Miriya K Tune; Dale O Cowley; Jason R Mock; Folami Ideraabdullah; Samir N P Kelada
Journal:  Mamm Genome       Date:  2020-08-29       Impact factor: 3.224

8.  The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages.

Authors:  Musa A Hassan; Vincent Butty; Kirk D C Jensen; Jeroen P J Saeij
Journal:  Genome Res       Date:  2013-11-18       Impact factor: 9.043

9.  Genetic dissection of the ity3 locus identifies a role for ncf2 co-expression modules and suggests selp as a candidate gene underlying the ity3.2 locus.

Authors:  Rabia Tahir Khan; Marie Chevenon; Kyoko E Yuki; Danielle Malo
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.